Cargando…

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report

SARS-CoV-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. We present a case of an immunocompromised patient with acquired B-cell deficiency who developed an indolent, protracted course of SARS-CoV-2 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Shiv, Klein, Jonathan, Robertson, Alexander J., Peña-Hernández, Mario A., Lin, Michelle J., Roychoudhury, Pavitra, Lu, Peiwen, Fournier, John, Ferguson, David, Mohamed Bakhash, Shah A. K., Catherine Muenker, M., Srivathsan, Ariktha, Wunder, Elsio A., Kerantzas, Nicholas, Wang, Wenshuai, Lindenbach, Brett, Pyle, Anna, Wilen, Craig B., Ogbuagu, Onyema, Greninger, Alexander L., Iwasaki, Akiko, Schulz, Wade L., Ko, Albert I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930970/ https://www.ncbi.nlm.nih.gov/pubmed/35301314 http://dx.doi.org/10.1038/s41467-022-29104-y

Ejemplares similares

Genomic Analysis of Early Monkeypox Virus Outbreak Strains, Washington, USA
por: Roychoudhury, Pavitra, et al.
Publicado: (2023)

Race and ethnicity do not impact eligibility for remdesivir: A single-center experience
por: Pischel, Lauren, et al.
Publicado: (2021)

ORF-Interrupting Mutations in Monkeypox Virus Genomes from Washington and Ohio, 2022
por: Sereewit, Jaydee, et al.
Publicado: (2022)

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
por: Hedskog, Charlotte, et al.
Publicado: (2023)

Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)
por: Mills, Margaret G., et al.
Publicado: (2022)

Curbing Ebola infections among healthcare workers in West Africa: unconventional strategies needed
por: Ogbuagu, Onyema Eberechukwu, et al.
Publicado: (2014)

1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
por: Hedskog, Charlotte, et al.
Publicado: (2022)

The SARS-CoV-2 Omicron Variant Does Not Have Higher Nasal Viral Loads Compared to the Delta Variant in Symptomatic and Asymptomatic Individuals
por: Laitman, Andrew M., et al.
Publicado: (2022)

Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences’ SARS-CoV-2 Multiplex Amplicon Sequencing Panel
por: Addetia, Amin, et al.
Publicado: (2020)

Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies
por: Ogbuagu, Onyema, et al.
Publicado: (2014)

Comparison of Time to Viral Suppression Among Treatment-Naïve HIV-Infected Adults Initiating Combination Antiretroviral Therapy by Antiretroviral Regimen Class
por: Jacobson, Karen, et al.
Publicado: (2017)

Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus–infected patients compared to non-nucleoside and protease inhibitor–based regimens in a real-world clinical setting: A retrospective cohort study
por: Jacobson, Karen, et al.
Publicado: (2018)

Clinical Performance Characteristics of the Swift Normalase Amplicon Panel for Sensitive Recovery of Severe Acute Respiratory Syndrome Coronavirus 2 Genomes
por: Shrestha, Lasata, et al.
Publicado: (2022)

Editorial: Pathogenesis of Leptospira
por: Wunder, Elsio A., et al.
Publicado: (2018)

Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda
por: Kambutse, Immaculate, et al.
Publicado: (2018)

Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates
por: Addetia, Amin, et al.
Publicado: (2020)

Fast SARS-CoV-2 Variant Detection Using Snapback Primer High-Resolution Melting
por: Lownik, Joseph C., et al.
Publicado: (2021)

SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
por: Lahmer, Tobias, et al.
Publicado: (2022)

A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
por: Tuan, Jessica, et al.
Publicado: (2021)

Narrow transmission bottlenecks and limited within-host viral diversity during a SARS-CoV-2 outbreak on a fishing boat
por: Hannon, William W., et al.
Publicado: (2022)

Narrow transmission bottlenecks and limited within-host viral diversity during a SARS-CoV-2 outbreak on a fishing boat
por: Hannon, William W, et al.
Publicado: (2022)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
por: Camprubí, Daniel, et al.
Publicado: (2021)

599. Expanding HIV Training in Internal Medicine Residency Program: A Prospect to Meet the HIV Workforce Demand
por: Barakat, Lydia, et al.
Publicado: (2018)

Correction: Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda
por: Kambutse, Immaculate, et al.
Publicado: (2019)

Molecular Analysis of SARS-CoV-2 Lineages in Armenia
por: Avetyan, Diana, et al.
Publicado: (2022)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance
por: Bourassa, Lori, et al.
Publicado: (2021)

1328. Post-War and Post-Ebola HIV Care Continuum in a Liberian Academic Center: Fresh Insights and Trends Over 5-Year Period
por: Watchekwa, Ian, et al.
Publicado: (2019)

1261. Alarming High Rate of HIV Detected by Testing and Prevention Opportunities: Observations From the Largest HIV Program in Liberia
por: Ogbuagu, Onyema, et al.
Publicado: (2019)

Genomic Characterization of Respiratory Syncytial Virus during 2022–23 Outbreak, Washington, USA
por: Goya, Stephanie, et al.
Publicado: (2023)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers, Ellen, et al.
Publicado: (2018)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora, Francis J, et al.
Publicado: (2019)

Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate
por: Addetia, Amin, et al.
Publicado: (2020)

Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants
por: Despres, Hannah W., et al.
Publicado: (2022)

Clinical Profile and Outcome of Patients with Acute Kidney Injury Requiring Hemodialysis: Two Years' Experience at a Tertiary Hospital in Rwanda
por: Igiraneza, Grace, et al.
Publicado: (2018)

Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients
por: Ogbuagu, Onyema, et al.
Publicado: (2018)

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
por: Baldi, Federico, et al.
Publicado: (2023)

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
por: Addetia, Amin, et al.
Publicado: (2020)

Phylogenetic estimates of SARS-CoV-2 introductions into Washington State
por: Tordoff, Diana M., et al.
Publicado: (2021)

HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
por: Ogbuagu, Onyema, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_amodonm32khrk9tl5btt5trlm5